Prothena Corporation plc
Biotechnology
Healthcare
PRTA
53.83 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.28
52 week high
22.11
high
8.35
52 week low
0.00
previous Close
8.29
P/E ratio
market cap
337 M
div yield
0
net profit margin
0.00 %
2128.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top